FDA Plugs HDE Program, Shows Flexibility With Population, Cost Criteria
This article was originally published in The Gray Sheet
Executive Summary
FDA is seeking broader use of the humanitarian device exemption program by encouraging dialogue with manufacturers about HDE requirements for patient population and cost